Comparative efficacy of newer hypnotic drugs for the short‐term management of insomnia: a systematic review and meta‐analysis
- 27 May 2004
- journal article
- research article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 19 (5), 305-322
- https://doi.org/10.1002/hup.594
Abstract
Objectives To compare the clinical effectiveness of zaleplon, zolpidem or zopiclone (Z‐drugs) with either benzodiazepines licensed and approved for use in the UK for the short‐term management of insomnia (diazepam, loprazolam, lorazepam, lormetazepam, nitrazepam, temazepam) or with each other. Methods MEDLINE, EMBASE, PsycINFO, Science Citation Index/Web of Science were searched from 1966 to March 2003 and The Cochrane Library, reference lists of included studies and a number of psychopharmacology journals. Randomized controlled trials comparing either benzodiazepines with the Z‐drugs or any two of the Z‐drugs in patients with insomnia were included. Outcome measures included: sleep onset latency, total sleep duration, number of awakenings, quality of sleep, adverse events, tolerance, rebound insomnia and daytime alertness. Results and conclusions Twenty four eligible studies were identified with a total study population of 3909 (17 studies comparing a Z‐drug with a benzodiazepine and 7 comparing a Z‐drug). Insufficient or inappropriately reported data meant that meta‐analysis was possible only for a small number of outcomes. There are few clear, consistent differences between the drugs. Some evidence suggests that zaleplon gives shorter sleep latency but shorter duration of sleep than zolpidem, reflecting the pharmacological profiles of the drugs. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
This publication has 18 references indexed in Scilit:
- Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mgHuman Psychopharmacology: Clinical and Experimental, 2003
- A Double-Blind Comparative Study of Zolpidem versus Zopiclone in the Treatment of Chronic Primary InsomniaJournal of International Medical Research, 2001
- Zaleplon improves sleep without producing rebound effects in outpatients with insomniaInternational Clinical Psychopharmacology, 2000
- Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statementThe Lancet, 1999
- Sleep Latency Is Shortened During 4 Weeks of Treatment With Zaleplon, a Novel Nonbenzodiazepine HypnoticPublished by Physicians Postgraduate Press, Inc ,1999
- Zaleplon, A Novel Nonbenzodiazepine Hypnotic, Effectively Treats Insomnia in Elderly Patients Without Causing Rebound EffectsThe Primary Care Companion For CNS Disorders, 1999
- S.06.04: The course of primary and secondary negative symptoms in a placebo-and comparator-controlled trial of the typical antipsychotic olanzapineEuropean Neuropsychopharmacology, 1996
- A Double-blind Placebo-controlled Trial of Zopiclone 7·5 mg and Temazepam 20 mg in InsomniaInternational Clinical Psychopharmacology, 1990
- Zopiclone: A Non-Benzodiazepine HypnoticThe British Journal of Psychiatry, 1985
- Comparison of Nitrazepam and Zopiclone in Psychiatric PatientsPharmacology, 1983